PUBLISHER: The Business Research Company | PRODUCT CODE: 2165548
PUBLISHER: The Business Research Company | PRODUCT CODE: 2165548
Blood glucose monitoring devices are medical devices designed to measure and monitor blood glucose levels in individuals with diabetes and other metabolic disorders. These devices enable patients and healthcare providers to track glucose fluctuations, manage treatment plans, and improve glycemic control through regular monitoring.
The primary product types of blood glucose monitoring devices include self-monitoring blood glucose systems, continuous glucose monitoring systems, and professional point-of-care devices. Self-monitoring blood glucose systems refer to portable devices that measure blood glucose levels using small blood samples, enabling individuals to monitor and manage glucose levels during routine care. These systems support testing at the fingertip, upper arm, and alternate sites and are used for diabetes management and health and wellness monitoring. The various applications include diabetes management and health and wellness monitoring, while end users include self or home care and hospitals and clinics.
Tariffs are influencing the blood glucose monitoring devices market by increasing the cost of imported sensors, semiconductors, test strips, electronic components, and medical-grade materials required for manufacturing glucose monitoring systems. This is raising production costs and device prices, particularly affecting Continuous Glucose Monitoring Systems, Self Monitoring Blood Glucose Systems, and Professional Point Of Care Devices in regions dependent on imports such as North America, Europe, and Asia-Pacific. Hardware-intensive product segments and healthcare providers relying on imported devices face the greatest impact due to global supply chain dependencies. However, tariffs are also encouraging local manufacturing, regional supplier diversification, and increased investment in domestic medical device production, strengthening long-term market resilience.
The blood glucose monitoring devices market research report is one of a series of new reports from The Business Research Company that provides blood glucose monitoring devices market statistics, including blood glucose monitoring devices industry global market size, regional shares, competitors with a blood glucose monitoring devices market share, detailed blood glucose monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the blood glucose monitoring devices industry. This blood glucose monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The blood glucose monitoring devices market size has grown rapidly in recent years. It will grow from $19.08 billion in 2025 to $21.02 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to increasing prevalence of diabetes, growing aging population, rising awareness of diabetes management, expanding healthcare expenditure, and improving access to diagnostic devices.
The blood glucose monitoring devices market size is expected to see strong growth in the next few years. It will grow to $30.43 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to growing demand for continuous glucose monitoring, increasing adoption of home healthcare, rising focus on preventive healthcare, expanding reimbursement support for diabetes care, and increasing incidence of obesity and metabolic disorders. Major trends in the forecast period include growing adoption of continuous glucose monitoring systems, increasing preference for non-invasive glucose monitoring technologies, rising demand for personalized diabetes management, expanding home-based blood glucose monitoring, and greater focus on early detection and glycemic control.
The rising prevalence of diabetes worldwide is expected to drive the growth of the blood glucose monitoring devices market in the coming years. Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels resulting from insufficient insulin production, impaired insulin action, or both. The rising prevalence of diabetes is attributed to increasing obesity rates, which significantly elevate the risk of developing type 2 diabetes. Blood glucose monitoring devices support diabetes management by enabling continuous glucose tracking, facilitating timely treatment adjustments, and reducing the risk of severe health complications. For instance, in March 2025, according to the UK Health Security Agency, a UK-based government public health organization, the GP-recorded prevalence of type 2 diabetes among adults aged 17 years and older in England increased from 6.8% in March 2023 to 7.0% in March 2024, representing an increase of approximately 2.9%. Therefore, the rising prevalence of diabetes worldwide is driving the growth of the blood glucose monitoring devices market.
Major companies operating in the blood glucose monitoring devices market are focusing on developing advanced products such as continuous glucose monitoring (CGM) systems to enable real-time glucose tracking, improve diabetes management, enhance patient convenience, and support better clinical outcomes. Continuous glucose monitoring (CGM) systems are wearable medical devices that continuously measure glucose levels in interstitial fluid and provide real-time glucose data, trends, and alerts to help individuals manage diabetes more effectively. For instance, in February 2023, Dexcom, a US-based medical device company, launched the Dexcom G7, a continuous glucose monitoring system. The device features a 30-minute sensor warm-up period, an all-in-one wearable sensor and transmitter design, and enhanced accuracy with a Mean Absolute Relative Difference (MARD) of approximately 8.2%. The system also enables real-time glucose sharing with caregivers and integration with compatible digital health platforms, improving the efficiency of diabetes management.
In August 2024, Abbott, a US-based manufacturer of continuous glucose monitors, partnered with Medtronic plc to integrate Abbott's continuous glucose monitoring technology with Medtronic's insulin delivery systems, enabling more connected and personalized diabetes management. The partnership aims to enhance blood glucose monitoring and insulin therapy by expanding interoperability between continuous glucose monitoring devices and automated insulin delivery systems for people with diabetes. Medtronic plc is an Ireland-based medical device company.
Major companies operating in the blood glucose monitoring devices market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic plc, DexCom Inc., LifeScan Inc., Ascensia Diabetes Care Holdings AG, Sinocare Inc., Arkray Inc., Nova Biomedical Corporation, TaiDoc Technology Corporation, i-SENS Inc., ACON Laboratories Inc., Bionime Corporation, Apex Biotechnology Corporation, OSANG Healthcare Co. Ltd., OK Biotech Co. Ltd., ALL MEDICUS Co. Ltd., Senseonics Holdings Inc., Biolinq Incorporated, GlucoTrack Inc., Know Labs Inc., Afon Technology Ltd.
North America was the dominant region in the blood glucose monitoring devices market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the blood glucose monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the blood glucose monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The blood glucose monitoring devices market consists of sales of blood glucose test strips, lancets, lancing devices, and blood glucose sensors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Blood Glucose Monitoring Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses blood glucose monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for blood glucose monitoring devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood glucose monitoring devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.